Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,219 JPY | -1.38% | +0.74% | +7.21% |
2023 | Fumakilla Limited Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2022 | Fumakilla Limited(TSE:4998) dropped from S&P Global BMI Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company appears to be poorly valued given its net asset value.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.21% | 130M | - | ||
-2.68% | 3.42B | C- | ||
-25.11% | 2B | C+ | ||
-12.82% | 1.85B | B- | ||
-4.41% | 1.76B | - | ||
-2.85% | 1.64B | - | ||
-14.56% | 1.16B | B | ||
+0.48% | 1.14B | - | ||
-23.39% | 1.01B | - | ||
-7.24% | 962M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4998 Stock
- Ratings Fumakilla Limited